10343521

Source:http://linkedlifedata.com/resource/pubmed/id/10343521

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0019878, umls-concept:C0025677, umls-concept:C0030705, umls-concept:C0032105, umls-concept:C0036078, umls-concept:C0086045, umls-concept:C0205195
pubmed:issue	2
pubmed:dateCreated	1999-6-3
pubmed:abstractText	To study the influence of sulphasalazine (SSZ), methotrexate (MTX), and the combination (COMBI) of both on plasma homocysteine and to study the relation between plasma homocysteine and their clinical effects.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-1358078, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-1764944, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-1768158, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-1934868, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-1973354, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-2132565, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-22555, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-2256738, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-2413074, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-2582708, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-2864741, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-3050087, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-3260783, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-4144775, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-7510620, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-7564788, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-7647779, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-7785955, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-7978695, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-7981992, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-8350329, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-8507221, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-8535642, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-8961899, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-9068801, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-9374925, http://linkedlifedata.com/resource/pubmed/commentcorrection/10343521-9517760
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372355
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Folic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Homocysteine, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Methylenetetrahydrofolate..., http://linkedlifedata.com/resource/pubmed/chemical/Oxidoreductases Acting on CH-NH..., http://linkedlifedata.com/resource/pubmed/chemical/Sulfasalazine, http://linkedlifedata.com/resource/pubmed/chemical/Vitamin B 12
pubmed:status	MEDLINE
pubmed:month	Feb
pubmed:issn	0003-4967
pubmed:author	pubmed-author:BlomH JHJ, pubmed-author:GiesendorfB ABA, pubmed-author:HaagsmaC JCJ, pubmed-author:van't HofM AMA, pubmed-author:van Oppenraaij-EmmerzaalDD, pubmed-author:van RielP LPL, pubmed-author:van de PutteL BLB
pubmed:issnType	Print
pubmed:volume	58
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	79-84
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:10343521-Antirheumatic Agents, pubmed-meshheading:10343521-Arthritis, Rheumatoid, pubmed-meshheading:10343521-Digestive System, pubmed-meshheading:10343521-Double-Blind Method, pubmed-meshheading:10343521-Drug Therapy, Combination, pubmed-meshheading:10343521-Female, pubmed-meshheading:10343521-Folic Acid, pubmed-meshheading:10343521-Homocysteine, pubmed-meshheading:10343521-Humans, pubmed-meshheading:10343521-Male, pubmed-meshheading:10343521-Methotrexate, pubmed-meshheading:10343521-Methylenetetrahydrofolate Reductase (NADPH2), pubmed-meshheading:10343521-Middle Aged, pubmed-meshheading:10343521-Mutation, pubmed-meshheading:10343521-Oxidoreductases Acting on CH-NH Group Donors, pubmed-meshheading:10343521-Sulfasalazine, pubmed-meshheading:10343521-Vitamin B 12
pubmed:year	1999
pubmed:articleTitle	Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.
pubmed:affiliation	Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't